In the development of terminology of the lower urinary tract, due to its increasing complexity, the terminology for male lower urinary tract and pelvic floor symptoms and dysfunction needs to be updated using a male-specific approach and via a clinically-based consensus report. Methods: This report combines the input of members of the Standardisation Committee of the International Continence Society (ICS) in a Working Group with recognized experts in the field, assisted by many external referees. Appropriate core clinical categories and a subclassification were developed to give a numeric coding to each definition. An extensive process of 22 rounds of internal and external review was developed to exhaustively examine each definition, with decision-making by collective opinion (consensus). Results: A Terminology Report for male lower urinary tract and pelvic floor symptoms and dysfunction, encompassing around 390 separate definitions/ descriptors, has been developed. It is clinically-based with the most common diagnoses defined. Clarity and user-friendliness have been key aims to make it interpretable by practitioners and trainees in all the different specialty groups involved in male lower urinary tract and pelvic floor dysfunction. Male-specific imaging (ultrasound, radiology, CT, and MRI) has been a major addition whilst appropriate figures have been included to supplement and help clarify the text. Conclusions: A consensus-based Terminology Report for male lower urinary tract and pelvic floor symptoms and dysfunction has been produced aimed at being a significant aid to clinical practice and a stimulus for research. Carlos D'Ancona (Content) and Bernard Haylen (Production) are equal first authors.
INTRODUCTION
There is currently no single document addressing all elements required for diagnoses applicable to adult (fully grown and physically mature 1 − new) male lower urinary tract and pelvic floor dysfunction. Indeed, the diagnostic entities themselves may have not been all completely defined. The term "diagnosis" is defined as "the determination of the nature of a disease; clinical: made from a study of the symptoms and signs of a disease 1 ; "laboratory:" investigative options to be mentioned. Such a specific report would require a full outline of the terminology for all symptoms, signs, urodynamic investigations for male lower urinary tract (LUT) and pelvic floor (PF) dysfunction, the imaging associated with those investigations and the most common diagnoses.
It may have been possible in the past to combine all terminology for lower urinary tract function for men, women and children into one Report. The International Continence Society (ICS) has provided leadership in terminology for lower urinary tract dysfunction over decades employing combined or generic reports. The 1988 2 and 2002 3 Reports by the Committee on Standardization of Terminology are such examples. With the increasing specificity and complexity of the diagnoses in both sexes, combined reports, let alone attempting to cover "all patient groups from children to the elderly," 3 may now be an anachronism. With evidence that the absence of specific female diagnoses as well as other female specific terminology, may not have been advantaged by a combined approach, 4 there occurred the development and 2010 publication of an International Urogynecological Association (IUGA)/ICS Joint Report on the Terminology for Female Pelvic Floor Dysfunction. 5 The 2002 Report 3 still provides the traditional core male terminology and some useful modifications, many of which are repeated in this document. The current report, with the large number of new and changed definitions, acknowledges that a male-specific update of terminology for LUT and PF symptoms and dysfunction is now timely.
It is hoped that some of the advantages noted in the female-specific document 5 might be seen here in this male document: (i) more comprehensive coverage of male-specific terminology; (ii) greater coherency and user-friendliness; (iii) greater specificity of male diagnoses; and (iv) more accurate communication for clinical and research purposes. It is also an aim in this document, to develop a general male terminology, forming a "backbone" or "core" terminology, to facilitate an update of the other subcategories of male-specific terminologies. There have been seven other (IUGA-ICS) female PFrelated terminology documents, [6] [7] [8] [9] [10] [11] [12] all published, following the production of the initial joint IUGA/ICS document on female pelvic floor dysfunction. 5 The authors of that document 5 have kindly permitted the template of that Report to be used as the basis for the current Report. Four other male terminology reports have been initiated: (i) male anorectal dysfunction; (ii) surgical management of male LUT dysfunction; (iii) sexual health in men with LUT/PF dysfunction and (iv) conservative management of male LUT/PF dysfunction, to follow the publication of this "core" report.
This Terminology Report is inherently and appropriately a definitional document, collating the definitions of those terms, that is, words used to express a defined concept in a particular branch of study, 1 here core male terminology. Emphasis has been on comprehensively including those terms in current use in the relevant peer-reviewed literature. The aim is to assist clinical practice and research. Explanatory notes on definitions have been referred, where possible, to the "Footnotes section." Table 1 lists the number of definitions: (i) new; (ii) changed; (iii) total by section, compared with the previous male-inclusive Reports. 2, 3 As with its female terminology equivalent, qualities for a male-specific terminology report should be:
(1) User-friendly: It should be able to be understood by all clinical and research users. (2) Clinically-based: Symptoms, signs, validated investigations and imaging should be presented for use in forming diagnoses. Sections 1-4 will address symptoms, signs, urodynamic investigations and current associated imaging modalities routinely used in the office, urodynamic laboratory, or imaging department to make those diagnoses. Readership is not assumed to be limited to medical specialists, accounting for a more extended "basic" physical examination (Section 2). Related radiological investigations, computerized tomography (CT) and magnetic resonance imaging (MRI) as well as a description of electromyography (EMG) has been included. This report limits terminology for neurogenic lower urinary tract dysfunction (LUTD) as this is covered by a separate ICS Report. 13 (3) Section 5 will address the most common diagnoses of male lower urinary tract and pelvic floor dysfunction. The terms 3 "urodynamic observation" and "condition" (nonmedical) have not been used in this report. The scope of the report will exclude (i) diagnostic pathology (blood, urine, histology); (ii) more invasive investigations requiring an anesthetic; (ii) evidence-based treatments for each diagnosis. (4) Origin: Where a term's existing definition (from one of multiple sources used) is deemed appropriate, that definition will be included and duly referenced. Many terms in male lower urinary tract and pelvic floor function, because of their long-term use, have now become generic, as apparent by their listing in medical dictionaries. (5) Able to provide explanations: Where a specific explanation is deemed appropriate to explain a change from earlier definitions or to qualify the current definition, this will be included as an addendum to this paper (Footnote [FN] 1,2,3 . . ..). Wherever possible, evidence-based medical principles will be followed.
As in earlier ICS Reports, 2,3,5 when a reference is made to the whole anatomical organ, the vesica urinaria, the correct term is the bladder. When the smooth muscle structure known as the m. detrusor vesicae is being discussed, then the correct term is detrusor.
It is suggested that acknowledgement of these standards in written publications related to male lower urinary tract and pelvic floor symptoms and dysfunction, be indicated by a footnote to the section "Methods and Materials" or its equivalent, to read as follows: "Methods, definitions and units conform to the standards recommended by the International Continence Society, except where specifically noted." Sensory symptoms 1.1.5 Bladder filling (sensory) symptoms: Abnormal sensations experienced during bladder filling. 1 (NEW) 1.
Increased bladder filling sensation:
Complaint that the sensation of bladder filling occurs earlier or is more intense or persistent to that previously experienced. 3, 5 (CHANGED) N.B. This differs from urgency by the fact that micturition can be postponed despite the desire to void. 1.1.5.2 Urgency: Complaint of a sudden, compelling desire to pass urine which is difficult to defer. 3, 5 FN1.5, FN1.6
Reduced bladder filling sensation:
Complaint that the sensation of bladder filling is less intense or occurs later in filling than previously experienced. (CHANGED) 1.1.5.4 Absent bladder filling sensation: Complaint of both the absence of the sensation of bladder fullness and a definite desire to void 3 1.1.5.5 Non-specific (atypical) bladder filling sensation (bladder dysesthesia): Complaint of abnormal bladder filling sensation such as the perception of vague abdominal bloating, vegetative symptoms (nausea, vomiting, faintness), or spasticity.
(CHANGED) F1.7 It differs from normal bladder filling sensation or pain, pressure or discomfort of the bladder. 16 1.1.6.2 Urgency urinary incontinence (UUI) 3, 5 : Complaint of involuntary loss of urine associated with urgency.
Incontinence symptoms 1.1.6 Urinary incontinence symptoms

Stress urinary incontinence (SUI):
Complaint of involuntary loss of urine on effort or physical exertion including sporting activities, or on sneezing or coughing. 3, 5 N.B. "activity (effort)-related incontinence" might be preferred in some languages to avoid confusion with psychological stress. FN1.10 1.1. 6 
.4 Mixed urinary incontinence (MUI):
Complaints of both stress and urgency urinary incontinence, that is, involuntary loss of urine associated with urgency as well as with effort or physical exertion including sporting activities or on sneezing or coughing (stress). 3,5 1.1.6.5 Enuresis: Complaint of intermittent (noncontinuous) incontinence that occurs during periods of sleep. 18 (CHANGED) 1.1.6.6 Continuous urinary incontinence:
Complaint of continuous involuntary loss of urine. 3, 5 (CHANGED) 1.1.6.7 Insensible urinary incontinence: Complaint of urinary incontinence where the individual is aware of urine leakage but unaware of how or when it occurred. 5 (CHANGED) 1.1.6.8 Postural urinary incontinence: Complaint of urinary incontinence during change of posture or position, for example, from supine or seated to standing. FN1.12 (NEW) 1.1.6.9 Disability associated incontinence:
Complaint of urinary incontinence in the presence of a functional inability to reach a toilet/urinal in time because of a physical (eg, orthopedic, neurological) and/or mental impairment. (NEW) 1.1.6.10 Overflow incontinence: Complaint of urinary incontinence in the symptomatic presence of an excessively (over-) full bladder (no cause identified). (NEW) 1.1.6.11 Sexual arousal incontinence 19 : Complaint of involuntary loss of urine during sexual arousal, foreplay and/or masturbation. (NEW) 1.1.6.12 Climacturia 19 : Complaint of involuntary loss of urine at the time of orgasm. (NEW) Storage symptom syndrome 1.1.7 Overactive bladder (OAB, urgency) syndrome:
Urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urinary incontinence (OAB-wet) or without (OABdry), in the absence of urinary tract infection or other detectable disease. 3 Footnotes for Section 1 1.1: Milsom et al. 15 first reported that frequency caused by an overactive bladder was arbitrarily defined as more than eight micturitions per 24 h, given that the normal voiding frequency in healthy individuals is typically under six micturitions per 24 h. It was higher than previously reported for healthy women using a frequency/volume chart (median 5.5 micturitions per 24 h). [15] [16] [17] 1.2: Pollakiuria: Complaint of abnormally (extraordinary 1 ) frequent micturition (rarely used definition).
1.3: It is common to void during the night when sleep is disturbed for other reasons-eg, insomnia-this does not constitute nocturia.
1.4: Polyuria is more fully defined in the "Signs" section. 1.5: "Urgency" replaces "urge" as the "accepted" terminology for the abnormal rather than the normal phenomenon.
1.6: The use of the word "sudden," defined as "without warning or abrupt," used in earlier definitions 2,3,5 has been subject to much debate. Its inclusion has been continued. 1.7: This symptom generally occurs where there is some form of neurological disease.
1.8: "Continence" is defined as absence of involuntary leakage of bowel and bladder contents (i.e. normal voluntary control of bowel and bladder function).
1.9: In each specific circumstance, urinary incontinence should be further described by specifying relevant factors such as type, severity, precipitating factors, social impact, effect on hygiene, and quality of life, the measures used to contain the leakage, and whether or not the individual seeks or desires help because of urinary incontinence.
1.10: This change is to accommodate for ambiguity in some languages between stress and anxiety. This symptom would most commonly occur in men who have undergone (radical) prostatectomy. Men who had radical prostatectomy may experience activity-related incontinence and/or during sex. 19 1.11: Small amounts of urine may be leaked without warning.
1.12: Men with post-prostatectomy incontinence do report this. It also happens in men after artificial sphincter placement. When they get up, they leak. Can be due to stress and without urge or other associated symptoms in the standing or upright position.
1.13: The term "pareuresis" is not in common usage, although the symptom is well-recognised. 20 Paruresis is defined as the fear of being able to urinate in situations where other persons are present. Diagnostic and statistical manual of mental disorders. Arlington, VA: American Psychiatric Association; 2013.
1.14: Dysuria is a type of urethral pain but could be urethral in origin or referred there from a pathological process in bladder, lower ureter or prostate.
1.15: The symptom of "stranguria" is poorly understood, overlapping at times with urethral pain, dysuria, and pelvic pain.
1.16: The bladder is distended, palpable, and possibly tender. A significantly increased residual is present.
1.17: Non-neurogenic chronic urinary retention (CUR) in men (AUA consensus 21 supported by the current authors) can be defined as an elevated post-void residual of greater than 300 mL that has persisted for at least 6 months and is documented on two or more separate occasions. Evidence is not strong. CUR can be caused by different pathologies that create detrusor underactivity and/or result in chronic bladder outlet obstruction. 21 1.18: May occur after clothing has been adjusted, due to some "pooling" of urine in the urethra if underwear, or clothing has caused some restriction during voiding or a urethral stricture or diverticulum.
1.19: Complaints of a slow urinary stream, hesitancy and straining to void, with or without sense of incomplete bladder emptying and dribbling, sometimes with storage symptoms: symptom grouping proposed to be suggestive of detrusor underactivity 22 (DU). Diagnosis of actual detrusor underactivity depends on urodynamic findings as discussed in Section 5 on Diagnoses.
1.20: It is often difficult to localize pain precisely, so descriptions as to location of the pain may be imprecise. For example, the term "bladder pain" does not necessarily indicate that the bladder is the cause. Pain thought to be arising from the bladder, or felt in the urethra, scrotum or perineum might be referred from the lower ureter, or bladder base or other pelvic organs.
1.21. The definitions of pelvic pain and especially chronic pelvic pain had been debated in several societies with a view to simplification and restructuring of the classification. The ICS has now published a report from chronic pelvic pain syndromes. 23 1.22. Painful ejaculation (previously termed "odynorgasmia"), is a poorly characterized syndrome. It may be associated with urethritis, BPH, acute or chronic prostatitis, CPPS, seminal vesiculitis, seminal vesicular calculi or ejaculatory duct obstruction. Often, no obvious etiologic factor can be found.
1.23: Commonly suggested criteria for: (i) Bacteriuria are>100 000 CFU/mL on voided specimen or >1000 CFU/ mL on catheterized specimen; (ii) Pyuria are >10 WBC/mm 3 in uncentrifuged urine. The presence of nitrites in the urine is supportive of a UTI involving a common organism (E. Coli, Klebsiella).
1.24: Those symptomatic patients with fewer colony counts may still harbor organisms detectable by mRNA analyses not widely available at present. 24 Testing for urinary microbiome is being explored but it is not widely available.
1.25: Recurrent urinary tract infections (UTIs) has not been consistently defined. They are far less common in men than women but perhaps more significant. There is the difficulty of balancing the practical clinical definition and the scientific one. Records of diagnostic tests are often inaccessible over the medium to longer term. With a bias towards the former category, a definition might be the presence at least two symptomatic and medically diagnosed UTIs in 12 months. "Recur" strictly means to "occur again" or "be repeated."
1.26: This symptom must have been present for at least 6 months and must be experienced on almost all or all (approximately 75-100%) occasions of sexual activity. It causes clinically significant distress in the individual. It has been called early ejaculation, rapid ejaculation, rapid climax or premature climax. There is no uniform cut-off defining "premature," but a consensus of experts at the International Society for Sexual Medicine endorsed a definition of around 1 min after penetration. The International Classification of Diseases (ICD-10) applies a cut-off of 15 s from the beginning of sexual intercourse.
1.27: Mean semen volume is 3.9 mL (5 th centile 1.5 mL; 95 th centile 6.8 mL). Low semen volume is under 1.5 mL; high semen volume is over 6.8 mL. 25, 26 1.28: Dyspareunia ("hispareunia"), the symptom most applicable to male discomfort on sexual intercourse, will depend on many factors including a woman's introital relaxation and/or anatomical factors.
1.29. Symptoms of defecatory dysfunction are not uncommon in men, particularly those who have undergone anal sphincterotomies for fissure-in-ano.
1.30. Rome IV Criteria for 1.8.3.1 Constipation 28 : Complaint that bowel movements are (i) infrequent (<3/ wk); (ii) need to strain; (iii) lumpy or hard stool bloating; (iv) sensation of incomplete evacuation; (v) sensation of anorectal obstruction or blockage abdominal pain, (vi) need for manual assistance, in more than one quarter of all defecation.
SECTION 2: SIGNS
Sign: Any abnormality indicative of disease or a health problem, discoverable on examination of the patient; an objective indication of disease or a health problem. 1 
(CHANGED)
General principles of examination for male with symptoms of LUT/PF dysfunction 29 : A comprehensive physical examination is done to seek potential influences on symptoms. FN2.1 It should include abdominal examination, focussing on the suprapubic area to detect an enlarged bladder, or other abdominal mass, and digital examination of the rectum (prostate) as well as examination of the external genitalia, the perineum and lower limbs. The hernia orifices should also be evaluated. Penile lesions including meatal stenosis, phimosis, and penile cancer must be excluded. [29] [30] [31] If a neurological diagnosis is suspected, then a focused neurological examination with evaluation of perianal crude and pinprick sensations need to be tested. Also, the anal muscle tone can be assessed with finger in the rectum and asking the patient to squeeze. (NEW) 
General (visual) observations
.3 Cystic dilatations of the epididymis:
(epididymal cysts or spermatocele) and hydroceles (fluid collections between the visceral tunica albuginea and parietal layer of the testicular peritoneum)-usually benign. The examination of these structures would be generally non-tender and without pain (as opposed to 2.3.3.2). metry, firmness, nodules, and its relation to the pelvic sidewall and rectum can be assessed. [35] [36] [37] The gland is about the size of a walnut and has a consistency similar to that of the contracted thenar eminence of the thumb 39 2.6.1.1 Perineal elevation 43, 44 : This is the inward (ventro-cephalad) movement of the perineum and anus. FN2. 13 Look for testicular lift and penile retraction. These need to be checked against movement of the scrotum and the whole penis. Correct movement occurs with the PFM only: the shaft of the penis draws in and the testes lift in a cephalad direction. These movements may be better visualized in standing than supine position. [45] [46] [47] (NEW) 2.6.1.2 Perineal descent 43 : This is the outward (dorso-caudal) movement of the perineum and anus. Footnotes for Section 2 2.1: There is little evidence from clinical trials that carrying out a clinical examination improves care, but general consensus suggests that it remains an essential part of assessment of men with urinary incontinence 2 or other LUTS.
Examinations
2.2: A normal bladder in the adult cannot be palpated or percussed until there is at least a volume of 150 mL of urine. At larger volumes of about ≥500 mL, a distended bladder may be visible in thin patients as a lower midline abdominal mass. Percussion is better than palpation for diagnosing a distended bladder. The examiner begins by percussing just above the symphysis pubis and continues cephalad until there is a change in tone from dull to resonant. 30 2.3: If phimosis is severe, this can cause voiding symptoms. Most penile cancers occur in uncircumcised men and arise on the prepuce or glans and may be associated with voiding symptoms. 33 2.4: Scrotal abnormalities can help in elucidating lower urinary tract symptoms in men. For example, men with epididymitis may have associated urinary infection symptoms secondary to coliform bacteriuria. 34 2.5: Isolated orchitis secondary to UTI is rare, however, mycobacterial infection, mumps, and BCG treatment may cause orchitis. 34 2.6: If very large they may distort the scrotum and urethra and interfere with normal voiding. A hydrocele is sometimes secondary to testis tumor or inflammatory processes in the epididymis or orchitis.
2.7: The presence of hernias, cystic swellings in the scrotum, and testicular tumors should be excluded by careful clinical examination.
2.8: During the DRE, prostate size and consistency can be estimated, although DRE tends to underestimate true prostate size. 35, 36 2.9: In patients with recto-urethral fistulas, the fistula can occasionally be palpated in the anterior rectal wall. The site of the fistula at or above the anal sphincter can occasionally be noted along with the degree of induration of the anterior rectal wall. With large fistulas the urethra can be palpated, especially if there is a Foley catheter in place.
2.10: For example, a person with Parkinson's may be unable to perform intermittent catheterization because of tremor. A focused neurological exam is also recommended, especially in patients suspected of having neurogenic bladder dysfunction. 38 Decreased perineal sensation and anal sphincter tone may be signs of neuropathy. 41 2.11: This reflex is most commonly tested by placing a finger in the rectum and then squeezing the glans penis. If a Foley catheter is in place, the BSR can also be elicited by gently pulling on the catheter. If the BSR is intact, tightening of the anal sphincter should be felt and/or observed. 39 The BSR tests the integrity of the spinal cord-mediated reflex arc involving S2-S4 and may be absent in the presence of sacral cord or peripheral nerve abnormalities. 39 2.12: If the patient has had previous urethral or bladder surgery or trauma, the examiner should ascertain whether urinary leakage occurs through a fistula in a scar, or at any other site in the penis, perineum, groins, or lower abdomen.
2.13: Normally there is inward (cephalad) movement of the perineum and anus.
2.14: This is all part of doing a DRE, assessing anal sphincters and puborectalis.
2.15: For the purposes of the nocturia terminology, night-time is therefore defined by the individual's sleep cycle, rather than the solar cycle (from sunset to sunrise). Thus, some shift workers may have their "night" period during the daylight hours, as it is the time of their main sleep period. 18 2.16: Volume measurement begins after the last void preceding sleep and concludes after the first daytime void. The first daytime void follows the individual's decision they will no longer attempt to sleep. 18 2.17: There are several definitions in the literature that could be used to indicate nocturnal polyuria including: 18 Nocturnal urine production based on body weight of greater than 10 mL/kg. 49 1. Rate of nocturnal urine production >90 mL/hr. 50 This is suggestive of nocturnal polyuria in men (about 450 mL per 8 h' sleep). 51 There are no studies looking at the rate of nocturnal urine production in women and this may well be different from that in men.
2.
Nocturnal polyuria index is the most commonly used definition for nocturnal polyuria 52 (nocturnal urine volume/24-hour voided volume) based on nocturnal urine volume as part of total 24-hour urine volume (age dependent).
Nocturia index (nocturnal urine volume/maximum
voided volume) 53 >1: nocturia occurs because maximum voided volume is smaller than nocturnal urine volume. >1.5: nocturia secondary to nocturnal urine over-production in excess of maximum bladder capacity, that is, nocturnal polyuria.
2.18:
A pad test quantifies the severity of incontinence and may be the most objective measure of the incontinence. Severity of incontinence (quantified by pad weight) affects surgery outcomes. The 24-hour pad test and micturition diary are reliable instruments for assessing the degree of urinary loss and number of incontinent episodes, respectively. Increasing test duration to 48 and 72 h D'ANCONA, HAYLEN ET AL..
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increases reliability but is associated with decreased patient compliance. 54 Overall, the 24-hour home test is the most accurate pad test for quantification and diagnosis of urinary incontinence because it is the most reproducible. 55 The 1-hour pad test may be used because it is easily done and standardized, however, there is no strict parallel with the 24-hour pad test and it may underestimate the weakness of the sphincter in the later part of the day. Figure 3B : the Liverpool nomograms 60 for the maximum urine flow rate (Q max ) in men aged over 50 years (mean 60 years). (NEW) The 25 th percentile appeared to be most appropriate lower limits of normality for both urine flow rates to identify those men more likely to have voiding dysfunction (more commonly bladder outlet obstruction [BOO]). 64 Higher urine flow rate percentiles occurred in men with detrusor overactivity. 64 FN3.3 Some racial differences in urine flow rates have been reported. FN3.4 Ideally, abnormal uroflowmetry studies should be repeated. (NEW)
Post-void residual (urine volume, PVR − unit:
mL): Volume of urine left in the bladder at the completion of voiding 2,3,5 (eg, by ultrasound) or by urethral catheterization (unless also "immediate" 
Intravesical pressure (P ves -unit: cm H 2 O):
The pressure within the bladder (as directly measured by the intravesical catheter). 2,3,56,57
Abdominal pressure (P abd -unit: cm H 2 O):
The pressure in the abdominal cavity surrounding the bladder. It is usually estimated from measuring the rectal pressure, though the pressure through a bowel stoma can be measured as an alternative. FN3.11 The simultaneous measurement of abdominal pressure is essential for interpretation of the intravesical pressure trace. 2, 3, 5 Artifacts on the detrusor pressure trace may be produced by a rectal contraction. 2,3,56,57 (CHANGED)
Detrusor pressure (P det -unit: cm H 2 O):
The component of intravesical pressure that is created by forces in the bladder wall (passive and active). It is calculated by subtracting abdominal pressure from intravesical pressure (P det = P ves -P abd ). 2 
Bladder sensation during filling cystometry:
Usually assessed by questioning the individual in relation to the fullness of the bladder during cystometry.
First sensation of bladder filling:
The feeling when the individual first feels bladder filling. 3 
Urethral function during filling cystometry (filling urethro-cystometry):
As filling urethro-cystometry is less well-explored in men than women, readers are referred to other reports for methodology. 56,57,80 3.6 Urethral closure mechanism 3.6.1 Normal urethral closure mechanism: A positive urethral closure pressure is maintained during bladder filling, even in the presence of increased abdominal pressure, although it may be overcome by detrusor overactivity.
Incompetent urethral closure mechanism:
Leakage of urine occurs during activities which might raise intra-abdominal pressure in the absence of a detrusor contraction. 82 The patient can achieve this by coughing (CLPP) or straining (Valsalva Leak Point Pressure − VLPP). The VLPP allows measuring the lowest pressure (measured by the bladder or abdominal pressure) that causes urine leakage. (c.f. the term "hypocontractile detrusor" or detrusor hypocontractility describes a detrusor contraction of reduced strength). Detrusor underactivity can be of neurogenic 13, 84 or nonneurogenic origin. (CHANGED) 3.7.3.3 Acontractile detrusor: The detrusor cannot be observed to contract (ie, no increase in P det ) during urodynamic studies resulting in failure to void (CHANGED). Limited voiding may occur by straining. The possibility of "inhibition" of a detrusor voiding contraction must be considered if the man subsequently voids normally postcystometry. An acontractile detrusor can be of neurogenic or non-neurogenic origin. Neurogenic acontractile detrusor should replace the term "detrusor areflexia."
Urodynamic stress incontinence (USI):
Pressure-Flow Studies
Urethral function during voiding:
This can be interpreted by the pressure-flow trace assisted at times by video cysto-urethrography (video-urodynamics − 4.3.4) and electromyography (EMG − 3.9) as available.
Normal urethral function during voiding:
Initiation of voiding begins with voluntary relaxation of the pelvic floor and striated sphincters (rhabdosphincter). The bladder then contracts with the bladder neck, the latter then opening due to its spiral arrangement of fibres. Voiding is prompted with the urethra being continuously relaxed to allow micturition at a normal detrusor pressure and urine flow, resulting in complete bladder emptying. 85, 86 FN3.24, FN3.25, FN3.26
Abnormal urethral function during voiding:
The urethral sphincter(s) do not relax completely or they are (temporarily) contracted during voiding, resulting in increased detrusor pressure. Bladder emptying may be complete or incomplete (PVR present). 87, 88 This is the generic term for obstruction during voiding. It is a reduced urine flow rate with a simultaneously increased detrusor pressure FN3.27. The Bladder Outlet Obstruction Index (BOOI = P det.
Bladder outlet obstruction (BOO):
Qmax -2Q max ) will give a guide to the likelihood of obstruction being present. 87 3.9 Electromyography (EMG) 3.9.1 Purpose: Reflects the activity of the striated musculature (peri-urethral, rhabdosphincter and pelvic floor). EMG is poorly standardized with variance in the type of needle, needle versus patch electrode, and electrode placement. 93 Perineal patch electrodes are often preferred for easier placement, patient tolerance and allow greater mobility. However, they measure all the above striated musculature. In contrast, needle electrodes can be placed in the area of interest and measure activity of defined muscles or muscle groups for example, rhabdosphincter. (NEW) 3.9.2 Interpretation: May be difficult due to artifacts introduced by other equipment. In the urodynamic setting, an EMG is useful as a gross indication of the patient's ability to control the pelvic floor. (NEW) 3.9.3 Detrusor-sphincter dyssynergia (DSD): Simultaneous contraction of the detrusor and (rhabdosphincter) urethral sphincters with the evidence of a neurological disorder (either visible or measurable neurological deficit or a history of neurological disease). The classification of DSD can be divided into two groups continuous versus intermittent. DSD type and degree of SCI lesions seem to correlate. 93, 94 (NEW) 3.9.3.1 Type 1 DSD occurs in patients with incomplete neurological lesions. Type 1 − there is a progressive increase in external urinary sphincter (EUS) contraction activity that peaks at maximal detrusor contraction followed by sudden relaxation of the EUS as the detrusor pressure declines allowing urination ( Figure 12 ). (NEW) 3.9.3.2 Type 2 DSD occurs more often in patients with complete lesions. Type 2 − occurs with continuous EUS contraction throughout the entire detrusor contraction resulting in urinary obstruction or inability to urinate. 93, 94 (NEW)
Ambulatory urodynamics:
A functional test of the lower urinary tract for which a transurethral catheter is placed in the bladder (and, in some protocols, another one in the rectum as is typical for a urodynamic study) performed outside the clinical setting, involving natural bladder filling by drinking and continuous recording of the bladder pressure (P ves ) for a longer period of time (eg, 12 h). Ambulatory urodynamics can reproduce bladder function and urine loss during the individual's normal everyday activities. (CHANGED) 3.11 Non-invasive urodynamics: The penile cuff 95 and condom catheter 96 and urethral device 97 have been developed as non-invasive alternatives to pressureflow studies. The principle of these tests is to interrupt the flow and measure the bladder pressure. The detrusor contraction is maintained and the urethral sphincter remains open; the column of fluid from the urethra to the bladder is sufficient to measure the bladder pressure (isovolumetric pressure). The external pressure on the urethra, which is needed to interrupt the flow, should be identical to the pressure in the bladder (ie, isovolumetric bladder pressure − P ves. iso ). Therefore, P ves.iso provides information on bladder pressure during voiding and, when urinary flow is also measured, it is able to distinguish between obstruction and non-obstruction ( Figure 11 ). 
Bladder neck during voiding:
Bladder neck opens like a funnel.
Bladder neck obstruction during voiding:
Bladder neck remains closed.
Footnotes for Section 3 3.1: Urodynamics is the general term to describe all the measurements that assess the function or dysfunction of the LUT by the measurement of relevant physiological parameters. 56, 57 3.2: Urodynamic tests: Over the years, a variety of terms have been developed for the group of diagnostic tests that evaluate LUT function: uroflowmetry, post void residual (PVR), cystometry, pressure-flow studies, electromyography (EMG), urethral pressure profile (UPP), and videourodynamics (videocystourethrography − VCU) are the terms most frequently used in the scientific literature. 56, 57 3.3: Men with detrusor overactivity had the highest urine flow rates. Detrusor overactivity (previously "instability") was present in 71% of men with centile rankings for the maximum urine flow rate over 50 mL/s. 64 3.4: There is a notable difference between the available nomograms (Liverpool, Siroky, and Bristol), particularly between race and in older patients. [60] [61] [62] [63] 3.5: These are figures for maximal diuresis in women in response to fluid loads of 500 mL and 1000 mL. the condition of the muscles fibers (detrusor). The isometric contraction of the detrusor, that is contraction without length modification or without shortening of the muscle fibers. Isovolumetric pressure is established by the isometric contraction of the detrusor (no flow). Isotonic contraction is developing force with length modification and therefore, shortening the muscle fibers. In this case, the isotonic pressure is referring to the fact that it is being developed in the voiding phase D'ANCONA, HAYLEN ET AL..
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Equivalent male diuresis data is unavailable. 65 However, maximum diluting capacity of urine is generally regarded as 20 L/day which converts to 13.9 mL/min (exactly the same as female data 65 ).
3.6: Not all catheters empty with similar efficacy. There is evidence in women that a less-compressible (silicone or plastic) catheter is much more effective than a more compressible (latex) catheter in draining the bladder. 66 Such evidence in men is unavailable.
3.7 Continuous fluid filling of the bladder via a transurethral (or other route, eg, cystostomy or Mitrofanoff) catheter, at least with intravesical and abdominal pressure measurement and display of detrusor pressure, including cough (stress) testing. Cystometry ends with "permission to void" or with incontinence of the total bladder content. The fluid type and temperature, filling method and rate, catheter sizes, pressure recording technique, and patient position should all be specified in the urodynamic protocol.
3.8: Body temperature fluid and room temperature fluid do not differently affect bladder sensory thresholds and do not unequally provoke detrusor overactivity or lower urinary tract irritation. 71, 72 3.9: Detrusor overactivity would have been missed in 76% of cases of cystometry was done in the supine position and 60% would have been missed if the study was done supine compared to seated 71, 73 . The sitting or standing position is the most representative for daily life situations and is probably the least uncomfortable and/or embarrassing for the patient. 73 3.10: Filling rate, especially when very fast and the volume infused is much larger than the functional bladder capacity, may influence the results or the representativeness of the cystometry. Evidence that filling rate should be changed during the cystometry is lacking. Diuresis, during cystometry, adds volume that is not recorded by the urodynamic system with automated filling volume recording, but that is relevant for interpretation of the results.
3.11: There is no specific evidence, but the position of the catheter-tip is usually above the bladder in a stoma, and bowel activity may much more likely cause artifacts in those cases, hampering measurement of absolute abdominal pressures, detrusor subtraction pressure, and therefore, the interpretation.
3.12: The urodynamic pressure is the excess pressure above atmosphere at the hydrostatic level of the upper edge of the symphysis pubis. This is valid for all pressures recorded with fluid-filled lines.
3.13: Values evaluated in healthy men 75, 76 (mean ± SD) are (i) First sensation of bladder filling: 222 mL ± 150 mL; (ii) First desire to void: 325 ± 140 mL; (iii) Strong desire to void: 453 ± 94 mL.
3.14:
Maximum cystometric capacity that should be in healthy adult men, mean 552 mL (range 317-927 mL). 76 3.15: Filling of more than 800 mL is seldom useful 71 . 3.16: Maximum bladder capacity under anaesthetic ("anatomical bladder capacity") − the volume to which the bladder can be filled under deep general or spinal anaesthetic, without urinary leakage, is rarely reported in scientific literature but may be of relevance in interstitial cystitis. 71 3.17: "Normo-active detrusor" as several studies have demonstrated detrusor overactivity during filling in healthy individuals.
3.18: UTI is a very uncommon cause of DO. Most centres do not do urodynamic studies in the presence of an active infection because of the risk of septicaemia.
3.19: Normal values of bladder compliance in men have not been well-defined. Bladder compliance in the volunteers was higher than usually considered normal in adults during cystometric bladder filling. 76 In 28 healthy volunteers, men with mean age of 24 years (range 19-28), the mean compliance was 56.1 mL/cm H 2 O (SD 37.3). Since no precise figures exist for normal compliance in men, a prospective study of a large normal population is needed.
3.20: There is no convincing evidence that the clinical diagnosis on the basis of the first cystometry is often changed on repetition of the test. There is no definite evidence that immediate repetition of an adequately performed urodynamic test "for confirmation" is required. The recommendation of immediate repetition of the test: (i) when doubt exists as to whether the test has answered the clinical question; (ii) when technical errors and artifacts have been observed at immediate post-test analysis.
3.21: Cystometry and pressure-flow study, free uroflometry and PVR are termed ICS standard urodynamic test (ICS-SUT). This may be supplemented with other tests such as EMG, imaging, continuous urethral pressure(s), and/or urethral pressure profile measurements. All tests are performed in the patient's preferred or most usual position: comfortably seated and/or standing if possible. 56, 57 3.22: Voiding physiology depends on central neural activation, bladder contractility and coordinated urethral relaxation throughout the process. There remains much to learn about these components including central activation and its potential grading, and its role and interactions in detrusor underactivity and dysfunctional voiding.
3.23: It is usually between 0.5 to 0.8 s depending on the individual's position and the distance to the uroflowmeter.
3.24: The first "event" in voiding is relaxation of the pelvic floor. This may mean a drop in intra-abdominal pressure in the rectal line, and an associated increase in the detrusor pressure which does not imply a detrusor contraction.
3.25: As any other muscular contraction, detrusor contraction has an isometric and an isotonic component. The isometric component means that detrusor fibers do not shorten and intravesical pressure rises. The isotonic component produces changes in fiber length; there is shortening and a flow ensues. The first is represented externally as P ves or P det and the second by flow. In voiding cystometry, in the presence of flow, detrusor pressure is a function of these two variables, governed by urethral resistance to flow.
3.26: Voluntary interruption of voiding: If the need to interrupt the flow were to arise, contraction of the pelvic floor and urethral sphincters can do this, resulting in an isometric detrusor pressure rise. Urine in the proximal urethra is milked back into the bladder.
3.27: In men with symptoms of lower urinary tract dysfunction, urine flow (rate) and PVR are important markers of bladder outlet obstruction, but are also dependent on the central initiation and continuation of the detrusor contraction and pressure. In the original definition, only pressure and urine flow were included. 3.28: Voiding cystometry graphic presentation: It has been recommended to present pressure-flow studies with a plot of the flow rate (mL/s) on the X-axis and the synchronous detrusor pressure (cm H 2 O) on the Y-axis in addition to the time-based graphs but the axis can be reversed. These plots can be added a cut-off value or a range of normality and equivocal zones. These cut-off values are population specific, varying widely among male patients.
The relation between detrusor pressure and generated synchronous flow indicate "urethral resistance." With computing, these plots can be drawn since the beginning to the end of flow. Urethral resistance is then appreciated graphically throughout the whole emptying phase. Most of these resistance points are considered to be driven by urethral muscular activity. The point of less calculated resistance should be taken as an approximation to the urethral resistance free of active muscular urethral and peri-urethral contractions. This concept of "passive urethral resistance relation" is then taken as an "anatomical obstruction" caused by fixed structures as the prostate or strictures.
Pressure-flow plots as a measure of detrusor voiding contraction. "Detrusor contractility" can be used for any method that diagnoses or aims to diagnose "intrinsic" detrusor muscle properties (eg, potential [maximum] force or velocity), by any method.
In a given group of patients the detrusor contractility can be calculated upon series of stop-flow or interrupted-voiding tests and mathematical or graphical analysis methods of pressure, flow and or other parameters. Cutoff values or a continuous scale of contractility can then be drawn. Independently of the magnitude of the detrusor contraction, it can be fading before the total emptying leading to incomplete voiding; "unsustained contraction" or "fading contraction" may then be used.
3.29: "ICS Nomogram" ® formerly known as Abrams-Griffiths Nomogram and "Abrams-Griffiths number" (now BOOI) is more commonly used.
3.30: Catheter flow should be compared with free flow to ascertain whether dysfunctional voiding might only occur during urodynamics due to catheter placement.
SECTION 4: IMAGING
Overview:
Imaging has become increasingly important in the assessment of male lower urinary tract and pelvic floor dysfunction. 
.3.4 Detrusor wall thickness (DWT) or bladder wall thickness (BWT):
Transabdominal visualization of the anterior bladder wall with a (linear) high frequency ultrasound scanner for the detection of BOO if DWT is ≥2 mm in bladders filled with ≥250 mL (Figure 14) or BWT is ≥5 mm in bladders filled with 150 mL (Figure 14 ). 101 by measuring the urine volume in the bladder and BWT and applying the following formula ( Figure 15 ). 106, 107 (NEW)
Intravesical Prostatic Protrusion (IPP):
Transabdominal measurement of the distance of the bladder base until the tip of the prostate in the bladder lumen 108 ( Figure 16A and B) . It is recommended to fill the bladder with 100-200 mL of fluid in order to receive representative measurements; bladder filling over 400 mL will lower IPP values. 108 The IPP measurement can be divided into three grades: grade I = 0-4.9 mm; grade II = 5-10 mm; grade III = >10 mm. 109 IPP grade III is associated with prostate-related BOO. 
FN4.5 (NEW)
Footnotes for Section 4 4.1: The "cut-off" value for obstruction has been suggested as 35 g (adult Asian men). 106 4.2: The potential of 3D and 4D ultrasound in male lower urinary tract and pelvic floor dysfunction is currently being researched with validated applications likely to be included in future updates of this Report and/ or separate ultrasound reports. 4.3: Diagnostic ability may be enhanced by the use of 3D MRI. New techniques with high speed sequence of pictures allows for a functional MRI. 4.4: Prostate imaging has over the last 5 years become more standardised with the introduction of PI-RADS (Prostate Imaging Reporting and Data System), currently version 2. The recommended MRI prostate protocol consists of multiparametric study which consists at least of a diffusion sequence (DWI), high resolution anatomical sequences (T2 weighted) and dynamic contrast enhanced sequences (perfusion imaging). A score is given according to each sequence finding and an overall PI-RADS score is finally given based on a structured reporting scheme. A score of 1-5 is given with one being benign and five being highly suspicious of malignancy. Ideally the MR studies are performed on a three Tesla strength MR scanner negating the need for an endorectal coil to achieve adequate resolution. MR spectroscopy imaging on the prostate is now rarely performed as it rarely adds value to the above multiparametric study.
SECTION 5: DIAGNOSES (MOST COMMON)
This report, like previous ones, 2,3,5 highlights the need to base diagnoses for male lower urinary tract and pelvic floor dysfunction on the correlation between a man's symptoms, signs and any relevant diagnostic investigations. We include EMG and imaging as possible diagnostic investigations. The diagnoses are categorized according to three subgroups that reflect the function of the lower urinary tract, namely storage, voiding dysfunction and mixed storage and voiding dysfunction. It should be noted that prevalence data for the relative frequency of the different male diagnoses are scarce. FN5 Footnotes for Section 5 5.1: Large series data on the relative frequency of diagnoses in men presenting with symptoms of LUT/PF dysfunction are scarce. The relative prevalence of six main diagnoses is known in women. 4, 5 In a series of 504 consecutive men 64 
5.2: Prevalence of Bladder Oversensitivity (BOS):
In the EPIC study, 115 the prevalence rate for men who void with frequencies of greater than eight times per day is approximately 12%. The presence of bladder oversensitivity in urogynaecology patients is 10-13%. 5 5.3: There should be no known or suspected urinary tract infection. Bladder oversensitivity is often a diagnosis after other more serious conditions such as lower urinary tract malignancy, including carcinoma-in-situ of the bladder, are excluded. 5.4: Prevalence of overall urinary incontinence in men by age: 116 19-44 (4.8%); 45-64 (11.2%); 65-79 (21.1%); >80 (32.2%) 5.5: Prevalence of urgency (urinary) incontinence in men by age 117 : 19-44 (3.1%); 45-64 (7.8%); 65-79 (11.7%); >80 (18.1%) 5.6: Abnormal detrusor contractions can be, at times, observed during filling cystometry without the patient being symptomatic. 5.7: Prevalence of urodynamic stress incontinence (USI): Prevalence of stress (urinary) incontinence in men by age: 115 19-44 (0.7%); 45-64 (3.8%); 65-79 (2.7%); >80 (N/A) or overall for men over 18 years 117 (1.4%). 5.8: Men, unlike women, do not develop significant urethral hypermobility (with radical prostatectomy a possible exception), and hence urodynamic stress incontinence is most often associated with intrinsic sphincter deficiency, rather than urethral hypermobility. Sphincter deficiency is most commonly a result of either pelvic trauma or post-prostatectomy, either transurethral or radical, or neurological disorder. 5.9 Prevalence for urinary incontinence after transurethral prostatectomy (TURP) for benign prostatic disease appears between 0.5% and 3%. [118] [119] [120] [121] [122] 5.10: Prevalence for post radical prostatectomy: The rates of post radical prostatectomy incontinence varies depending on the definition used and the duration of follow-up. However, the long-term incidence ranges between 4% and 8%. [117] [118] [119] [120] [121] [122] 5.11: Prevalence of either detrusor underactivity (DU) or acontractility (DAC): In a study involving a review of urodynamic data of 1179 patients aged 65 and older, Jeong et al. reported the prevalence of DUA of 40.2 % in men. 123 5.12: Urodynamic BOO can be diagnosed using the ICS Nomogram 89 . The formula used, known as the bladder outlet obstruction index (BOOI) is calculated by detrusor pressure at maximum flow (P det.Qmax ) minus two times the maximum urinary flow (BOOI = P det.Qmax -2 Q max ). A BOOI with a value of >40 defines BOO, less than 20 defines absence of BOO, and in between denotes equivocal BOO. Alternative classifications for BOO are the Schäfer grades (0-VI) 90, 91 and CHESS classification. 92 5.13 The evidence in men regarding PVR and BOO is not clear. Urodynamic studies in adult male patients with clinical BPH demonstrated that approx. 30% of men with PVR ≥50 mL do not have BOO/BPO, independent on the magnitude of PVR 124 and, vice versa, 24% of men with urodynamically confirmed BOO/BPO have PVR <50 mL or even 0 mL. [124] [125] 5.14: The level of obstruction can usually be diagnosed during voiding video cysto-urethrography. It may be aided by sphincter or pelvic floor EMG during voiding. 5.15: Bladder outlet obstruction from an enlarged prostate: BOO where the cause is benign prostatic enlargement (BPE) with clinical or imaging evidence. 5.16: Bladder outlet obstruction from the bladder neck: BOO where the cause is at the level of the bladder neck (clinical or radiological). The pelvic floor electromyogram (EMG) trace should be quiet during voiding in these patients.
5.17: Bladder outlet obstruction from pelvic floor muscular overactivity: Bladder outflow obstruction where the cause is at the level of the pelvic floor musculature (clinical, urodynamic or radiological). The pelvic floor electromyogram (EMG) trace may not be positive during voiding. 5.18: Bladder outlet obstruction from the rhabdosphincter (external urinary sphincter): BOO where the cause is at the level of rhabdosphincter (clinical, urodynamic or radiological). The pelvic floor electromyogram (EMG) trace may not be positive during voiding. 5.19: Bladder outlet obstruction from stenosis of bladder neck or urethra due to fibrosis: Bladder neck stenosis may occur secondary to prostate surgery for benign disease, radical prostate surgery, radiotherapy or trauma. 5.20: Currently, although many experts in this field agree that this entity exists, there is currently no consensus on its definition because there is currently no consensus on defining detrusor underactivity. There is a Maastricht-Hannover Nomogram 126 may be used to diagnose reduced detrusor contractility in the presence of obstruction (or vice versa). 5.21: Up to 83% 127 of men with urodynamic BOO may have concomitant urodynamic DO. Both BOO-grade and advancing age were independent factors of DO in men. The more severe BOO, the higher the chance of DO.
AREAS FOR FURTHER RESEARCH
In the preparation of this document, the following "gaps" in knowledge in male LUT/PF dysfunction have been noted compared to the equivalent for female LUT/PF dysfunction: 5 Post-void residuals in men with symptoms of LUT/PF dysfunction. Male diuresis data. Bladder compliance − normal and abnormal values in men. Additional large patient series for the prevalence data and the relative frequency of the most common male diagnoses. 64
ACKNOWLEDGMENTS/ADDENDUM
No discussion on terminology should fail to acknowledge the fine leadership shown by the ICS over many years. The legacy of that work by many dedicated clinicians and scientists is present in all the Reports by the different Standardization Committees and Working Groups. It is pleasing that the ICS leadership has accepted this vital initiative as a means of progress in this important and most basic area of Terminology and its Standardization. 
